Thus, despite the limitations of rat studies, the results showed that treatment with BPC 157 led to the recovery of tail function and the resolution of spasticity and improved the neurologic recovery
Without L-carnitine, this process would be much less efficient
Topical limitations: Limited penetration beyond superficial skin layers
however, it has associated side effects of weight gain and adverse metabolic effects (increasing the potential risk of high cholesterol or diabetes)
If growth hormone optimization is the target, CJC-1295/Ipamorelin is often sufficient without layering additional compounds
Constipation, interestingly, shows relatively flat rates across doses, with relative risks around 4.17 to 4.41 regardless of dose level